- Chart
- Upturn Summary
- Fund Details
Upturn AI Summary
VanEck Israel ETF(ISRA)
Advisory History & Simulated Performance *
*as per simulation (see disclosures)- ALL
- 1Y
- 1M
- 1W
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- PASS (Skip)
Advisory Performance History (Simulated)
Upturn Advisory & Investor View for ISRA
11/20/2026: ISRA (1-star) is currently NOT-A-BUY. Pass it for now.
The VanEck Israel ETF (ISRA) provides targeted exposure to the Israeli equity market by tracking the BlueStar Israel Global Index, capturing both locally listed firms and global companies with deep Israeli ties. Its main strengths include specialized access to world-class cybersecurity and tech innovation sectors backed by a reputable issuer. The primary portfolio role is serving as a satellite allocation for international diversification or a tactical play on Israeli market recovery. Key risks involve high single-stock concentration, regional geopolitical tensions, and relatively thin trading liquidity. It best suits investors seeking targeted geographic exposure while monitoring regional risk factors and liquidity conditions.
How to Read the Upturn Advisory
The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.
ETF holdings, costs, diversification, valuation, risks, and market conditions provide supporting context about the fund.
Investor Fit
| Investor style | Fit | Why |
|---|---|---|
| Growth investor | Strong fit | Strong allocation to high-growth cybersecurity and software enterprises fits growth mandates. |
| Momentum investor | Strong fit while signal remains positive | Momentum appeal tracks positive breakouts in underlying tech holdings and Israeli market recoveries. |
| Value investor | Mixed fit | Valuations are heavily influenced by growth-oriented tech components rather than deep value metrics. |
| Dividend/Income investor | Weak fit | The fund prioritizes capital appreciation and total equity exposure over high dividend yields. |
| Low-risk investor | Weak fit | Geopolitical risks and emerging-market style volatility render it unsuitable for low-risk profiles. |
Investor Profile
Ideal Investor Profile
Tactical or strategic international equity investors seeking dedicated exposure to Israeli innovation, technology, and financial sectors who are comfortable with geopolitical volatility.
Suitability
Best suited for tactical allocators and long-term thematic investors rather than passive core-portfolio index followers or active day traders.
Risk Profile
| Risk factor | Level | Why it matters |
|---|---|---|
| Volatility | Medium / high | Exhibits notable price swings driven by sector concentration and geopolitical headlines. |
| Market risk | High | Vulnerable to systemic downturns in both global equities and the Israeli regional market. |
| Concentration | High | Significant weight concentrated in top holdings like Palo Alto Networks and Teva. |
| Tracking/expense | Medium | An expense ratio of 0.59% introduces a moderate ongoing fee drag relative to broad-market index funds. |
| Liquidity | Medium / high | Lower average daily volume compared to larger flagship ETFs can impact execution costs. |
| Business/sector quality | Medium | Underlying firms feature solid fundamentals, though regional security situations introduce operating risks. |
Sector & Industry Intelligence
This fund is not assigned to one sector.
Risk Analysis
Volatility
ISRA exhibits medium-high historical volatility due to its concentration in growth-oriented technology names and exposure to regional geopolitical headlines.
Market Risk
Subject to substantial market risk stemming from local economic conditions in Israel, currency fluctuations, and shifts in global risk sentiment toward emerging and frontier-adjacent markets.
What the ETF Owns
| Exposure Type | Exposure | Weight (%) | Retail Investor Read |
|---|---|---|---|
| Single stock | Palo Alto Networks, Inc. (PANW) | 12.68 | |
| Single stock | Teva Pharmaceutical Industries Limited (TEVA) | 8.98 | |
| Industry | Israeli Financials (Bank Leumi, Bank Hapoalim, etc.) | 20 | |
| Industry | Technology and Software (Check Point, JFrog, etc.) | 25 | |
| Geography | Global and Domestic Israeli Equities | 33.34 |
Price Behavior

Rolling Over
The price momentum is slowing down and beginning to turn downward.

Smooth
The stock has moved along a generally orderly path with only modest fluctuations.
Analysis of Past Performance
Type ETF | Historic Profit 51.22% | Avg. Invested days 79 | Today’s Advisory PASS |
Upturn Advisory Rating ![]() | Upturn Advisory Performance | ETF Returns Performance |

Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.
All company names, trademarks, logos, and brands are the property of their respective owners and are used for identification and informational purposes only. Use of these names, trademarks, and logos does not imply endorsement by their respective owners.

